BCN2018-EBF-slides-2

European
Bioanalysis
Forum

EBF vzw is the registered non-profit organisation of the European Bioanalysis Forum

Slides of EBF within BCN-2018

PDF renditions of the EBF powerpoint presentations can be viewed and downloaded from this page by clicking the highlighted point on the program.

Day 1 – Wednesday 21 NOV 2018
Day 1-02: Future Bioanalytical Landscape
*Philip Timmerman, EBF*
Future challenges for BioA
*Matthew Barfield, on behalf of the EBF*
Singlet or Duplicate analysis in LBA?
*Marianne Scheel Fjording, on behalf of the EBF*
EBF Biomarker Strategies – a new deal?

Day 1-03: Regulatory Feedback on and/or interactions with FDA, MHRA, ICH
*Jo Goodman, on behalf of the EBF*
Updates on the Immunogencity Guidelines (EMA/FDA) and feedback from regulatory discussions from the recent EBF Autumn Focus Workshop
Philip Timmerman, EBF
ICH M10: Updates on the process and progress

Day 1-04 Jupiter: Immunogenicity 1
*Barry van der Strate, on behalf of the EBF*
Critical Reagents for ADA assays: an EBF perspective

Day 2 – Thursday 22 NOV 2018
Day 2-02 Auditorium: Scientific Validation/Fit for Purpose Round table
Introduction to the session

Day 2-02 Jupiter: New Technologies: LBA
WS 1: Technology Development
– EBF Intro
WS 2: e-Environment / Data Integrity
– EBF Intro
WS 3: Biomarkers
– EBF intro and case studies
WS 4: Automation
– EBF Survey data
WS 5: qPCR current application in bioanalysis
– EBF intro and survey

Day 3 – Friday 23 NOV 2018
Day 3-01 Auditorium: LC-MS Technical Applications
*Organisers of the 5th EBF Young Scientist Symposium*
To Bioanalysis and Beyond!

Day 3-02 Auditorium: Practical Implementation of FDA 2018 BMV Guidance
EBF Case studies and/or survey results

Slides of EBF within BCN-2018

Day 1 – Wednesday 21 NOV 2018

Day 2 – Thursday 22 NOV 2018

Day 3 – Friday 23 NOV 2018